{"id":"https://openalex.org/W2052829077","doi":"https://doi.org/10.1016/s0301-472x(98)00051-4","title":"Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein","display_name":"Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2052829077","doi":"https://doi.org/10.1016/s0301-472x(98)00051-4","mag":"2052829077","pmid":"https://pubmed.ncbi.nlm.nih.gov/10089904"},"language":"en","primary_location":{"id":"doi:10.1016/s0301-472x(98)00051-4","doi":"https://doi.org/10.1016/s0301-472x(98)00051-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(98)00051-4","pdf_url":"http://www.exphem.org/article/S0301472X98000514/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052829077"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.exphem.org/article/S0301472X98000514/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068645650","display_name":"Sharon Bowen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon Bowen","raw_affiliation_strings":["Roche Research Center, F. Hoffmann-La Roche, Nutley, NJ, USA","Roche Research Center, Drug Discovery, F. Hoffmann-La Roche, Nutley, NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Research Center, F. Hoffmann-La Roche, Nutley, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"Roche Research Center, Drug Discovery, F. Hoffmann-La Roche, Nutley, NJ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057832661","display_name":"Nadine S. Tare","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nadine Tare","raw_affiliation_strings":["Roche Research Center, Drug Discovery, F. Hoffmann-La Roche, Nutley, NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Research Center, Drug Discovery, F. Hoffmann-La Roche, Nutley, NJ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012289135","display_name":"Tomoaki Inoue","orcid":"https://orcid.org/0000-0002-3829-3908","observed_orcids":["https://orcid.org/0000-0002-3829-3908"]},"institutions":[{"id":"https://openalex.org/I4210112136","display_name":"Roche (Japan)","ror":"https://ror.org/01vepzj85","country_code":"JP","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210112136"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomoaki Inoue","raw_affiliation_strings":["Department of Toxicology, Nippon Roche Research Center, Kamakura, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, Nippon Roche Research Center, Kamakura, Japan","institution_ids":["https://openalex.org/I4210112136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109242483","display_name":"Motoo Yamasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Motoo Yamasaki","raw_affiliation_strings":["Tokyo Research Laboratories, Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Research Laboratories, Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026791776","display_name":"Masami Okabe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masami Okabe","raw_affiliation_strings":["Pharmaceutical Research & Development Division, Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research & Development Division, Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054847389","display_name":"Ikuo Horii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112136","display_name":"Roche (Japan)","ror":"https://ror.org/01vepzj85","country_code":"JP","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210112136"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ikuo Horii","raw_affiliation_strings":["Department of Toxicology, Nippon Roche Research Center, Kamakura, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, Nippon Roche Research Center, Kamakura, Japan","institution_ids":["https://openalex.org/I4210112136"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110017807","display_name":"James F. Eliason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"James F Eliason","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Institute, Detroit, MI USA","Department of Internal Medicine, Wayne State School of Medicine, Detroit, MI USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Institute, Detroit, MI USA","institution_ids":["https://openalex.org/I4210090317"]},{"raw_affiliation_string":"Department of Internal Medicine, Wayne State School of Medicine, Detroit, MI USA","institution_ids":["https://openalex.org/I185443292"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5110017807"],"corresponding_institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":null,"fwci":2.6627,"has_fulltext":true,"cited_by_count":82,"citation_normalized_percentile":{"value":0.88220919,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"27","issue":"3","first_page":"425","last_page":"432"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.19200000166893005,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.19200000166893005,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.08720000088214874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.07620000094175339,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyethylene-glycol-conjugates","display_name":"polyethylene glycol conjugates","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9350000023841858},{"id":"https://openalex.org/keywords/muteins","display_name":"muteins","score":0.8059999942779541},{"id":"https://openalex.org/keywords/molecular-weight","display_name":"molecular weight","score":0.6809999942779541},{"id":"https://openalex.org/keywords/neutrophil-count","display_name":"neutrophil count","score":0.8679999709129333},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.8870636224746704},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8375125527381897},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.8092951774597168},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.6549404263496399},{"id":"https://openalex.org/C58121356","wikidata":"https://www.wikidata.org/wiki/Q182854","display_name":"Molecular mass","level":3,"score":0.6525500416755676},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.6184276342391968},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6058072447776794},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5729472637176514},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5252577662467957},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4720918536186218},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4497891068458557},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3594096302986145},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3463374972343445},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32811596989631653},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22927641868591309},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2239551544189453},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15310978889465332},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1421547532081604},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006410","descriptor_name":"Hematopoiesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008970","descriptor_name":"Molecular Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0301-472x(98)00051-4","doi":"https://doi.org/10.1016/s0301-472x(98)00051-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(98)00051-4","pdf_url":"http://www.exphem.org/article/S0301472X98000514/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},{"id":"pmid:10089904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10089904","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental hematology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1016/s0301-472x(98)00051-4","doi":"https://doi.org/10.1016/s0301-472x(98)00051-4","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(98)00051-4","pdf_url":"http://www.exphem.org/article/S0301472X98000514/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2052829077.pdf","grobid_xml":"https://content.openalex.org/works/W2052829077.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W20604194","https://openalex.org/W202042235","https://openalex.org/W1525268289","https://openalex.org/W1584310604","https://openalex.org/W1790036423","https://openalex.org/W1879366539","https://openalex.org/W1975174081","https://openalex.org/W1978464652","https://openalex.org/W1998470807","https://openalex.org/W2002783109","https://openalex.org/W2010506651","https://openalex.org/W2016011359","https://openalex.org/W2042662552","https://openalex.org/W2050149613","https://openalex.org/W2080165371","https://openalex.org/W2156945455","https://openalex.org/W2179246640","https://openalex.org/W2197241554","https://openalex.org/W2289122463","https://openalex.org/W2294454082","https://openalex.org/W2342048368","https://openalex.org/W2405604079","https://openalex.org/W2412455219","https://openalex.org/W2415430772"],"related_works":["https://openalex.org/W1986848620","https://openalex.org/W2416194831","https://openalex.org/W171017154","https://openalex.org/W2016479172","https://openalex.org/W2016796926","https://openalex.org/W1584310604","https://openalex.org/W2486686769","https://openalex.org/W2015087741","https://openalex.org/W1587083983","https://openalex.org/W2033616994"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2052829077","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
